For Clinics & Hospitals
Department-grade intelligence with zero new headcount. Plug-and-play, insurable against a certified SIL-4-grade bound, and ready for global regulation. Empower your clinical teams with a system that removes diagnostic bottlenecks, mitigates risk, and elevates the standard of care across your entire institution.
What changes
Specialist-grade support across every department, without hiring.
Fits the systems you already run, with a clean integration path.
A quantified, SIL-4-grade error bound means your AI exposure can be priced, not excluded.
Documentation, audit, and uncertainty handling built in, not bolted on.
Strategic Insight
A complete blueprint for integration, clinical validation, and financial impact. Available exclusively for medical professionals and hospital administration.
Clinical validation
The retrospective proof is published. The prospective layer comes next: SILENT-DS — a multi-site, silent-mode, non-interventional study, pre-registered before the first patient and reported to the STARD-AI standard, whatever the results.
The system runs in parallel on routinely collected record data. No new clicks, no workflow change — treating clinicians never see its output during the study, so care cannot be disturbed.
Missed-critical capture, time-to-diagnosis, top-3 concordance with the final diagnosis, and deferral discipline — adjudicated by an independent, blinded committee. Your clinicians are not graded; site data is reported in aggregate.
ICMJE co-authorship on a registered multi-site study, a sponsor-funded on-premises node (air-gapped configuration available), coordination support, and aggregate insight into your own diagnostic timelines.
If the system flags a possibly missed life-threatening condition, an independent senior physician reviews the record and may advise your team to consider it. Logged, adjudicated, reported.
De-identification at the source; the hospital remains data controller; identifiable data never leaves the building. The ethics and data-protection pack (including a DPIA) comes prepared for your committee.
Sites activate on a rolling basis under one pre-registered protocol. Early sites are named in the primary publications.
Participation is subject to feasibility review, a site agreement, and local ethics approval. The protocol becomes final upon pre-registration.